VALSECCHI, MARIA GRAZIA
VALSECCHI, MARIA GRAZIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Archimedean Copulas: A Useful Approach in Biomedical Data—A Review with an Application in Pediatrics
2025 Risca, G; Galimberti, S; Rebora, P; Cattoni, A; Valsecchi, M; Capitoli, G
Are there any benefits of prolonged hypothermic oxygenated perfusion? - Results from a national retrospective study
2025 De Carlis, R; Lauterio, A; Schlegel, A; Gringeri, E; Patrono, D; Camagni, S; Dondossola, D; Pezzati, D; Olivieri, T; Pagano, D; Bongini, M; Montanelli, P; Ravaioli, M; Bernasconi, D; Valsecchi, M; Baccarani, U; Cescon, M; Andorno, E; Mazzaferro, V; Gruttadauria, S; Di Benedetto, F; Ghinolfi, D; Caccamo, L; Pinelli, D; Romagnoli, R; Cillo, U; De Carlis, L; Perin, L; Petronio, N; Del Prete, L; Balzano, E; Vacca, P; Germinario, G; Basilico, G; Romano, P
Clock-reset “log-rank-type” test to assess the impact of the intermediate event in a non-markovian illness-death model
2025 Bernasconi, D; Tassistro, E; Rebora, P; Valsecchi, M; Antolini, L
Considerations on neurological deficits in patients with glioblastoma: impact of perilesional resection on neuro-oncological outcome. A monocentric real-life experience
2025 Di Cristofori, A; Rui, C; Graziano, F; Ferlito, D; Rebora, P; Trezza, A; Chiarello, G; Stefanoni, G; Da Re, F; Julita, C; Basso, G; Palumbo, G; Valsecchi, M; Carrabba, G; Giussani, C
Correction to: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey (BMC Geriatrics, (2025), 25, 1, (138), 10.1186/s12877-025-05695-1)
2025 Cavalli, A; De Vincentis, A; Pedone, C; Laudisio, A; Santoro, L; Ferrara, M; Trevisan, C; Tassistro, E; Valsecchi, M; Castoldi, G; Mussi, C; Sergi, G; Ungar, A; Volpato, S; Papalia, R; Incalzi, R; Bellelli, G
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey
2025 Cavalli, A; De Vincentis, A; Pedone, C; Laudisio, A; Santoro, L; Ferrara, M; Trevisan, C; Tassistro, E; Valsecchi, M; Castoldi, G; Mussi, C; Sergi, G; Ungar, A; Volpato, S; Papalia, R; Incalzi, R; Bellelli, G
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation
2025 Lussana, F; Magnani, C; Galimberti, S; Gritti, G; Gaipa, G; Belotti, D; Cabiati, B; Napolitano, S; Ferrari, S; Moretti, A; Buracchi, C; Borleri, G; Rambaldi, B; Rizzuto, G; Grassi, A; Paganessi, M; Meli, C; Tettamanti, S; Risca, G; Pais, G; Spinozzi, G; Benedicenti, F; Cazzaniga, G; Capelli, C; Gotti, E; Introna, M; Golay, J; Montini, E; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles
2025 Silvagni, E; Bortoluzzi, A; Occhino, G; Bellelli, G; Garaffoni, C; Delvino, P; Leoni, O; Valsecchi, M; Scirè, C; Rebora, P
Investigating sarcopenia in pediatric Crohn's Disease with magnetic resonance enterography: An observational study
2025 Calia, M; Rebora, P; Gandola, D; Norsa, L; Maino, C; Romanchuk, A; Sansotta, N; Panceri, R; Valle, C; Valsecchi, M; Biondi, A; Ippolito, D; Zuin, G
Letermovir Primary and Secondary Prophylaxis in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplant
2025 Vendemini, F; De Lorenzo, P; Romani, F; Malandrin, S; Verna, M; Bonanomi, S; Valsecchi, M; Lucchini, G; Balduzzi, A
Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapy
2025 Rossi, A; Romano, R; Fecarotta, S; Dell'Anno, M; Pecorella, V; Passeggio, R; Zancan, S; Parenti, G; Santamaria, F; Borgia, F; Deodato, F; Funghini, S; Rupar, C; Prasad, C; O'Callaghan, M; Mitchell, J; Valsecchi, M; La Marca, G; Galimberti, S; Auricchio, A; Brunetti-Pierri, N
Population-based validation of a frailty index using electronic regional healthcare records for public health use
2025 Rebora, P; Occhino, G; Bellelli, G; Leoni, O; Casazza, S; Valsecchi, M; Galimberti, S; Scirè, C
Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysis
2024 Tassistro, E; Bernasconi, D; Valsecchi, M; Antolini, L
Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP‐ALL cell survival and a potential therapeutic target
2024 Taurino, G; Dander, E; Chiu, M; Pozzi, G; Maccari, C; Starace, R; Silvestri, D; Griffini, E; Bianchi, M; Carubbi, C; Andreoli, R; Mirandola, P; Valsecchi, M; Rizzari, C; D'Amico, G; Bussolati, O
Basket trials in very rare diseases: are they feasible?
2024 Risca, G; Zheng, H; Valsecchi, M; Galimberti, S
Basket trials in very rare diseases: are they feasible?
2024 Risca, G; Zheng, H; Valsecchi, M; Galimberti, S
BIVARIATE COPULA MODELS IN THE PRESENCE OF COMPLEX PATTERNS FOR THE SURROGATE ENDPOINT FOR A SURVIVAL TRUE ENDPOINT
2024 Capitoli, G; Rotolo, F; Risca, G; Galimberti, S; Valsecchi, M
Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis
2024 Faverio, P; Maloberti, A; Rebora, P; Intravaia, R; Tognola, C; Toscani, G; Amato, A; Leoni, V; Franco, G; Vitarelli, F; Spiti, S; Luppi, F; Valsecchi, M; Pesci, A; Giannattasio, C
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome
2024 Consiglieri, G; Tucci, F; De Pellegrin, M; Guerrini, B; Cattoni, A; Risca, G; Scarparo, S; Sarzana, M; Pontesilli, S; Mellone, R; Gasperini, S; Galimberti, S; Silvani, P; Filisetti, C; Darin, S; Forni, G; Miglietta, S; Santi, L; Facchini, M; Corti, A; Fumagalli, F; Cicalese, M; Calbi, V; Migliavacca, M; Barzaghi, F; Ferrua, F; Gallo, V; Recupero, S; Canarutto, D; Doglio, M; Tedesco, L; Volpi, N; Rovelli, A; La Marca, G; Valsecchi, M; Zancan, S; Ciceri, F; Naldini, L; Baldoli, C; Parini, R; Gentner, B; Aiuti, A; Bernardo, M
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study
2024 Conter, V; Valsecchi, M; Cario, G; Zimmermann, M; Attarbaschi, A; Stary, J; Niggli, F; Dalla Pozza, L; Elitzur, S; Silvestri, D; Locatelli, F; Moricke, A; Engstler, G; Smisek, P; Bodmer, N; Barbaric, D; Izraeli, S; Rizzari, C; Boos, J; Buldini, B; Zucchetti, M; Von Stackelberg, A; Matteo, C; Lehrnbecher, T; Lanvers-Kaminsky, C; Cazzaniga, G; Gruhn, B; Biondi, A; Schrappe, M